Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers

NCT02442739 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI voluntary closure due to low accrual

Conditions

Head and Neck Cancer
Pancreatic Cancer
Depression

Interventions

DRUG: Ketamine
OTHER: Placebo

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]